U.S. Media Stock News

In the recent Q3 earnings season, TriCo Bancshares reported revenue growth of 8.5% year on year and surpassed analyst expectations on revenue, earnings per share, and tangible book value per share. This broad-based outperformance versus consensus suggests investors are reassessing how effectively TriCo Bancshares is managing its balance sheet and profitability metrics. We will now examine how this stronger-than-expected earnings performance shapes TriCo Bancshares' investment narrative and...

Olin (OLN) cut its Q4 2025 adjusted EBITDA outlook to about US$67 million, down from a prior range of US$110 million to US$130 million, citing maintenance, downtime at Freeport, Texas, and softer pipeline chlorine demand. See our latest analysis for Olin. Even with the reduced Q4 2025 outlook, the stock has been volatile, with a 1-day share price return of 5.76% and a 7-day share price return of 10.72%. The 1-year total shareholder return decline of 20.26% and 3-year total shareholder return...

Tutor Perini (TPC) drew fresh attention after announcing a roughly US$53 million change order for Honolulu’s City Center Guideway and Stations Project. This expands its role in designing new rail segments and two additional stations. See our latest analysis for Tutor Perini. The contract news comes after a period of firm share price momentum, with Tutor Perini’s latest share price at US$70.53 and a 90 day share price return of 13.28%. Its 1 year total shareholder return of 195.24% and 3 year...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...

We wouldn't blame Nuvalent, Inc. ( NASDAQ:NUVL ) shareholders if they were a little worried about the fact that James...

Despite an already strong run, Binah Capital Group, Inc. ( NASDAQ:BCG ) shares have been powering on, with a gain of...

We'd be surprised if Relay Therapeutics, Inc. ( NASDAQ:RLAY ) shareholders haven't noticed that the CEO, President...

Some Denali Therapeutics Inc. ( NASDAQ:DNLI ) shareholders may be a little concerned to see that the Co-Founder, Ryan...

Key Insights Given the large stake in the stock by institutions, Fractyl Health's stock price might be vulnerable to...

What Costamare’s Latest Dividend Move Signals for Investors Costamare (CMRE) recently reaffirmed its income profile by declaring a quarterly dividend of $0.115 per common share, along with scheduled payments on its Series B, C, and D preferred shares. For common shareholders, the $0.115 dividend relates to the quarter ended December 31, 2025 and is payable on February 5, 2026 to investors on record as of January 20, 2026. Preferred investors are set to receive $0.476563 per Series B share,...

Why 3D Systems Is Back on Investor Radar 3D Systems (DDD) is drawing fresh attention after expanding its U.S. facilities, securing 510(k) clearance for its VSP Orthopedics platform, and advancing defense work supported by the National Defense Authorization Act. See our latest analysis for 3D Systems. These updates have arrived during a volatile stretch, with a 7 day share price return of 25.95% and a 30 day gain of 22.63% following a 90 day decline of 25.08%. At the same time, the 1 year...

Stock performance snapshot and recent context Cullen/Frost Bankers (CFR) has attracted fresh attention from investors after recent share price moves, with the stock showing positive returns over the past week, month, past 3 months, and year to date. Over the past week the stock returned 5.9%, with gains of 5.1% over the past month and 8.3% over the past 3 months. Year to date, the total return stands at 5.9%, while the 1 year total return is 5.6%. See our latest analysis for Cullen/Frost...

Potential Dorian LPG Ltd. ( NYSE:LPG ) shareholders may wish to note that the Chairman of the Board, John Hadjipateras...

In recent days, First American Financial reported higher quarterly revenue and net profit than the prior year, while Barclays’ Terry Ma reaffirmed a Hold rating and analysts maintained a Moderately Buy-leaning consensus view. This combination of improving financial performance and broadly constructive analyst sentiment may be reshaping how investors assess the company’s earnings profile and resilience. Next, we’ll examine how the stronger quarterly results could influence First American...

Recently, Paymentus Holdings reported that it continues to upgrade its cloud-based billing and payment platform and deepen integrations across utilities, municipalities, healthcare, and government, while management reaffirmed its full-year outlook for steady growth and improving margins. An interesting angle is how these enhancements in essential recurring payment flows may strengthen Paymentus’ role as infrastructure-like software for billers across multiple regulated sectors. Next, we’ll...

In recent days, O’Reilly Automotive’s past five-year performance and its upcoming fiscal Q4 2025 earnings announcement have drawn attention, as analysts anticipate improved earnings following stronger-than-expected Q3 2025 results and a raised full-year revenue outlook driven by solid demand for replacement auto parts. The company’s historical compounding of returns and analysts’ continued strong buy consensus highlight how consistent execution in the auto parts market can materially...

Pomerantz LLP recently announced it is investigating potential claims on behalf of investors of Village Farms International, Inc., inviting affected shareholders to contact the firm for more information. This type of investor-focused legal review can intensify scrutiny of Village Farms’ governance and disclosures, adding a new layer of risk perception around the company. We’ll now examine how this investor legal investigation could influence Village Farms International’s cannabis-focused...

In recent updates, Celldex Therapeutics reported progression of its antibody pipeline, including global Phase 3 trials for barzolvolimab in chronic urticarias and early-stage data for bispecific antibody CDX-622. A key insight for investors is Celldex’s cash runway reportedly extending through 2027, supporting continued development of these late- and mid-stage programs. Next, we’ll explore how this pipeline momentum, particularly the Phase 3 barzolvolimab program, shapes Celldex...

Why the latest earnings report matters for AdaptHealth AdaptHealth (AHCO) recently reported quarterly revenue of US$820.3 million, which came in 2.5% above analyst estimates, with full year guidance aligned to market expectations despite slower growth compared with peers. This mix of modest outperformance and steady guidance has drawn fresh attention to the stock as investors weigh how a slower growing home medical equipment provider fits into a sector facing labor cost and reimbursement...

Over the past year, Inspire Medical Systems has faced multiple class action lawsuits alleging it misled investors about demand, preparedness, and execution for its Inspire V next‑generation sleep apnea device launch, alongside operational rollout issues highlighted by at least one institutional investor exiting its position. These legal challenges and execution concerns sit in sharp contrast to prior enthusiasm about Inspire’s technology, underscoring how operational follow-through and...

If you are wondering whether EVERTEC at around US$30.17 is offering value right now, you are not alone. This article is built to help you weigh what that price might really mean. The stock has returned 5.2% over the last 7 days and 1.5% over the last 30 days, while year to date it is up 5.2%. However, its 1 year, 3 year and 5 year returns of 4.5%, 11.1% and 19.3% declines tell a different story. Recent attention on EVERTEC has been shaped more by its share price history and sector sentiment...

Jack Henry & Associates (JKHY) is back in focus after a cluster of analyst upgrades and a fresh core banking deal with Sanibel Captiva Community Bank, putting its fintech franchise under renewed investor scrutiny. See our latest analysis for Jack Henry & Associates. The recent core banking win with Sanibel Captiva Community Bank and a wave of analyst upgrades have coincided with a 24.29% 90 day share price return and an 11.46% 1 year total shareholder return, pointing to momentum that...

Nomad Foods recently outlined a plan to streamline its operations between 2026 and 2028 targeting US$200 million in cost savings, while continuing share repurchases and maintaining a dividend yield of 5.8% supported by current earnings. Insider share purchases at decade-low valuation levels, alongside consistent free cash flow generation and ongoing buybacks that have reduced the share count by about 4% annually since 2021, underline management’s confidence in the business. We’ll now examine...

With a price-to-earnings (or "P/E") ratio of 27.9x Veralto Corporation ( NYSE:VLTO ) may be sending bearish signals at...